Ropes & Gray represented Sanofi Ventures in connection with its investment in Bionyra Pharma’s record-breaking $165 million Series A financing.
Bionyra Pharma is a clinical-stage biopharmaceutical company developing next-generation biologics for immune-mediated inflammatory diseases. The financing marks a record for a French biotech and one of the largest Series A financings globally for a company dedicated to human health.
The round was co-led by Jeito Capital and Sofinnova Partners, with participation from Arkin Bio, Sanofi Ventures, Sixty Degree Capital, Vives Partners and Apollo Health Ventures.
The Ropes & Gray team included private equity counsel Raphaël Durand, private equity partner Emmanuel Mimin, and venture capital and emerging companies partner Rajarshi Banerjee.
Attorneys
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.


